REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharma Cid S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pharma Cid S.A.S. Profile Updated: May 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Pharma Cid S.A.S. is an enterprise based in Colombia. Its main office is in Bogota D.C.. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on September 28, 1990. It currently has a total number of 8 (2024) employees. From the latest financial highlights, Pharma Cid S.A.S. reported a net sales revenue increase of 140.72% in 2023. Its total assets grew by 26.92% over the same period. The net profit margin of Pharma Cid S.A.S. increased by 8.2% in 2023.

Headquarters
Cr 78 # 64C-31
Bogota D.C.; Bogota D.C; Postal Code: 0912

Contact Details: Purchase the Pharma Cid S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Pharma Cid S.A.S. report to view the information.
Outstanding Shares:
Purchase the Pharma Cid S.A.S. report to view the information.
Incorporation Date:
September 28, 1990
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pharma Cid S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
140.72%
Total operating revenue
140.72%
Operating profit (EBIT)
322.8%
Net Profit (Loss) for the Period
386.07%
Total assets
26.92%
Total equity
52.43%
Operating Profit Margin (ROS)
8.16%
Net Profit Margin
8.2%
Return on Equity (ROE)
23.6%
Quick Ratio
-0.79%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?